et . the role of endoscopy in the assement and treatment of esophageal cancer . gastrointest endosc 2013 ; 77 : 328-34 . 2. siewert j , feith m , werner m , stein h. adenocarcinoma of the esophagogastric junction : results of surgical therapy based anatomical/topographic classification in 1002 consecutive patient . ann surg 2000 : 232 : 353-61 . 3. ajani j , bentrem d , besh d , et . nccn guidelines esophageal and esophagogastric juntion cancers . version 2 . 2013. : http : //www.nccn.org/professionals/physician_gls/pdf/esophageal.pdf ( conexión 5-5-2013 ) . 4. choi j , kim j , jung h , song i. comparison of endoscopic ultrasonography ( eus ) , po - sition emission tomography ( pet ) and computed tomography ( ct ) in the preoperative locoregional staging of resectable esophageal cancer . surg endosc 2010 ; 24 : 1380-6 . 5. kleinberg l , powell m , forastiere , et . survival outcome of e1201 : an eastern cooperative oncology group ( ecog ) randomized phase ii trial of neodjuvant preope - rative paclitaxel/cisplatin/radiotherapy ( rt ) or irinotecan/cisplatin/rt in endoscopy with ultrasound ( eus ) staged esophageal adenocarcinoma . j clin oncol 2008 ; 26 ( suppl 15 ) : 4532 . 6. wu t , chirieac l , abraham s , et . exellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esopha - gogastric junction carcinoma : reliable predictor for patient outcome . ann j surg pathol 2007 ; 31 : 58-64 . 7. tepper j , krasna m , niedzwiecki d , et . phase iii trial of trimodality therapy with cis -rené g.121 platin , fluoracil , radiotherapy , and surgery compared with surgery alone for esophageal cancer : calgb 9781. j clin oncol 2008 ; 26 : 1086-92 . 8. van hagen p , hulshof m , van lanschot j , et . preoperative chemoradiotherapy for esophageal or junctional cancer . n engl j med 2012 ; 366 : 2074-84 . 9. swisher s , hofstetter w , komaki r , et . improved long-term outcome with chemora - diotherapy strategies in esophageal cancer . ann thorac surg 2010 ; 90 : 892-8 . 10. braghetto i , cardemil g , burdiles p. esofaguectomía mini invasiva toracoscópica laparoscópica . rev chil cir 2005 ; 57 : 118-20.cáncer esófago123 dr. antonio rollán rodríguez introducción infección helicobacter pylori ( h. pylori ) constituye probablemente infección crónica extensamente difundida especie humana , afectando 50 % población mundial 90 % viven países vías de-sarrollo . h. pylori coloniza forma casi exclusiva superficie apical epitelio gástrico , desencadenando respuesta inflamatoria local ( gastritis ) intensidad extensión variables respuesta inmune sistémica fácilmente evidenciable . embargo , respuesta inmune específica capaz eliminar bacteria , mayoría casos , persiste toda vida individuo . epidemiología infección h. pylori ampliamente extendida mundo , presenta distribución bimodal . pequeño grupo países , pertenecientes mundo desarrollado , presenta frecuencias oscilan 20 40 %